Primary Site >> Colorectal Cancer

Gene >> GALNT14

  • 2010
  • 2016
  • 2018
Ref: Development of immunohistochemistry assays to assess GALNT14 and FUT3/6 in clinical trials of dulanermin and drozitumab.
PMID: 20179215
 Ref: GALNT14 Genotype Predicts Postoperative Outcome of Stage III Colorectal Cancer With Oxaliplatin as Adjuvant Chemotherapy.
PMID: 27124048
 Ref: Prognostic Stratification of Advanced Gastric Signet Ring Cell Carcinoma by Clinicopathological Factors and GALNT14 Genotype.
PMID: 30310511